The role of the local microenvironment in influencing cell behavior is central to both normal development and cancer formation. Here, we show that sprouty 1 (SPRY1) modulates the microenvironment to enable proper mammary branching morphogenesis. This process occurs through negative regulation of epidermal growth factor receptor (EGFR) signaling in mammary stroma. Loss of SPRY1 resulted in up-regulation of EGFR-extracellular signal-regulated kinase (ERK) signaling in response to amphiregulin and transforming growth factor alpha stimulation. Consequently, stromal paracrine signaling and ECM remodeling is augmented, leading to increased epithelial branching in the mutant gland. By contrast, down-regulation of EGFR-ERK signaling due to gain of Sprouty function in the stroma led to stunted epithelial branching. Taken together, our results show that modulation of stromal paracrine signaling and ECM remodeling by SPRY1 regulates mammary epithelial morphogenesis during postnatal development.
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branching morphogenesis | FGF signaling | EGF signaling | epithelial-stromal interactions | stromal microenvironment A central theme in developmental and cancer biology research is to understand the mechanisms by which the local microenvironment, or niche, influences fundamental aspects of cell and tissue behavior during organ formation and function (1) . The importance of mesenchyme, as the embryonic niche, in determining organ identity and fate of the epithelium was demonstrated long ago by classic embryological studies (2, 3) . More recent studies have shown, however, that postnatal stroma, a derivative of embryonic mesenchyme, is essential for maintenance of cell fate and differentiation status in adult life (4, 5) . Indeed, abnormal stroma can lead to the formation of a cancer microenvironment, and it plays a causative role during tumor onset and progression (1, 6) . As such, understanding postnatal stromal biology and the mechanism by which its deregulation may promote tumorigenesis is of key importance.
The mouse mammary gland is a powerful model for understanding the genetic and cellular basis of stromal biology (7) . The observation that epithelial branching of the mammary gland persists for many weeks after birth has made amenable the detection of stromal influences on epithelial invasion and patterning (8, 9) . Indeed, postnatal mammary stroma is composed of many cell types, including periductal fibroblasts and white adipocytes, endothelial cells, nerve cells, and a variety of infiltrating immune cells, including macrophages and eosinophils, which play an important role in postnatal branching (10) .
Mammary stroma regulates epithelial branching by at least two mechanisms. Stromal cells produce several paracrine factors, including fibroblast growth factors (FGFs) and insulin-like growth factor (IGF) that activate receptor tyrosine kinases (RTK) (11, 12) . For example, a reduction in FGF signaling due to loss of FGF10 or its receptor FGF receptor 1/2 (FGFR1/2), or reduced IGF signaling, leads to stunted epithelial branching (13) (14) (15) (16) . By contrast, excessive FGF signaling due to overactive FGF ligand or receptor causes breast tumorigenesis in mouse models (17) (18) (19) . In addition, stromal cells also play a major role in remodeling of the ECM, whose unique physical, biochemical, and biomechanical properties make it an essential component for a wide variety of developmental processes including epithelial branching (1, 6) . ECM remodeling is highly regulated and its deregulation is a major contributor to tumorigenesis (20) .
The postnatal mammary gland stroma is under both systemic hormonal and local control based on epithelial-derived paracrine signaling via, for example, the EGF receptor (EGFR) pathway (21) . Whereas a reduction in stromal EGFR signaling due to genetic ablation of the receptor or its ligands, including amphiregulin (AREG) and transforming growth factor alpha (TGFα), leads to deficient epithelial branching (22) (23) (24) , excessive EGFR signaling causes breast tumorigenesis and is a therapeutic target of human cancer (25, 26) . Thus, stromal EGFR signaling is important for epithelial branching of the mammary gland.
Significance
Despite its importance in epithelial development and in breast cancer, the role of EGF receptor (EGFR) signaling and its regulation in the postnatal mammary stroma has remained unclear. Here, we show that sprouty 1 (Spry1) modulates epithelial-stromal interactions by inhibiting EGFR-dependent stromal paracrine signaling and ECM remodeling. Spry1 loss leads to upregulated EGFR signaling and enhanced stromal activities, including ECM remodeling and growth factor production, and ultimately increased epithelial branching. By contrast, EGFR signaling reduction in fibroblasts leads to stunted epithelial branching. We show that EGFR and FGF receptor (FGFR) signaling constitute a critical part of stromal-epithelial interactions during postnatal development and that these signaling pathways are fine-tuned by different members of the Sprouty gene family to ensure normal epithelial morphogenesis of the mammary gland.
Despite its requirement for epithelial branching, the mechanisms by which EGFR signaling functions and is modulated in the mammary gland stroma have remained unclear. Here, we hypothesized that members of the Sprouty family, which encode intracellular RTK signaling inhibitors essential for numerous vertebrate developmental processes (27) (28) (29) (30) , regulate EGFR signaling in the mammary gland stroma. To test this hypothesis, we determined the mammary gland phenotype in mice lacking sprouty 1 (Spry1) and analyzed the mechanisms by which SPRY1 functions. These studies revealed an important role for SPRY1 in mammary gland stromal-epithelial cross talk.
Results
Spry1 Is Expressed in Mammary Stroma and Basal Epithelium. We examined the expression of Spry1 during various stages of postnatal mammary gland development. Spry1 mRNA was readily detected at all of the stages examined by quantitative real-time PCR (qPCR), including during epithelial branching, pregnancy, lactation, and involution ( Fig. 1A) . We used fluorescence-activated cell sorting (FACS) to sort mammary epithelia based on their expression of CD24 and CD49f cell surface markers ( Fig. 1B) . Spry1 was highly expressed in basal (CD24 med CD49f hi ) and stromal (CD24 neg CD49f neg ) cells compared with low levels in luminal cells (CD24 hi CD49f low ) (Fig. 1C) .
To assess the spatiotemporal patterns of Spry1 expression during mammary gland development, we took advantage of Spry1 LacZ/+ (Spry1 heterozygous, Spry1het) mice carrying the Spry1 LacZ allele, which is a null allele that also reports Spry1 expression due to replacement of essential functional domains by the LacZ gene (31) . Spry1 was expressed in many tissues of the developing embryo at embryonic day 12.5 (E12.5) ( Fig. 1 D and  D′) , including both the mammary bud epithelium and mesenchyme ( Fig. 1E ). In pubertal mammary glands, when epithelial branching is ongoing, we detected Spry1 expression in the branching epithelial network and blood vessels in the distal stroma ( Fig. 1F ). Histological sections of stained mammary glands confirmed that Spry1 is expressed in periductal fibroblasts ( Fig. 1 G and H) , cap cells of terminal end buds (Fig. 1H ), and the basal ductal epithelium ( Fig. 1G ), but there was little expression in the luminal epithelium.
Loss of Spry1 Function Leads to Increased Branching Activities in the Mammary Epithelium. We examined whether the mammary gland develops normally in mice lacking Spry1 function. Compared with mammary glands from pubertal and adult virgin Spry1 +/+ [Spry1 wild-type (Spry1wt)] mice, those from Spry1 LacZ/+ (Spry1het) mice did not show any significant differences in ductal penetration, terminal end buds (TEBs), or branching ( Fig. S1 A-D).
These findings were consistent with previously reported haplosufficiency of Sprouty genes in various vertebrate developmental processes (27, 32, 33) . However, when we compared mammary glands from pubertal and adult virgin Spry1het and Spry1 LacZ/LacZ [Spry1 knockout (Spry1KO)] female mice, we found significant differences in epithelial morphogenesis. In mice at 8 and 12 wk of age, the epithelium of the KO animals reached further into the fat pad ( Fig. 1 I and J). Moreover, at 8 wk of age, mammary glands from Spry1KO mice showed increased number of TEBs ( Fig. 1K ) and increased branching ( Fig. 1L ).
Interestingly, this branching phenotype was resolved at 12 wk of age. The lack of overall major defects in Spry1KO mammary glands suggests that other family members could compensate for loss of Spry1. Indeed, Spry2 (30) and Spry4 were expressed in the mammary gland ( Fig. S1 E-G), although Spry3 was not detectable. The spatiotemporal pattern of Spry4 expression was most similar to Spry1, suggesting that Spry4 may be redundant for Spry1.
These results reveal that Spry1 negatively regulates epithelial invasion and branching in pubertal mammary gland. However, our data suggest that the loss of Spry1 can be overcome by other Spry proteins later in development.
Spry1 Loss in the Mammary Epithelium Does Not Affect Mammary
Branching. Our observation that Spry1 is expressed in both the epithelium and the stroma of the mammary gland indicated that the branching phenotype of Spry1KO mice could result from defects in either compartment. Considering its expression in the basal layer, which is rich in adult stem cells (34) , we asked whether Spry1 is essential for mammary stem cell biology and thus epithelial expansion during branching morphogenesis. We used the mammosphere assay (35) , which measures progenitor/stem cell potential of mammary epithelial cells based on their ability to survive and form mammospheric colonies in suspension (primary mammosphere assay) and to self-renew (secondary mammosphere assay), with two commonly used growth factors, EGF and/or FGF2. We observed no statistically significant difference in mammosphere forming efficiency between Spry1het and Spry1KO cells in all cases ( Fig. 2 A and B , and Fig. S2 A and B) .
Similarly, using the acinar assay (36) , which measures the ability of mammary epithelial progenitor/stem cells to form acinus-like colonies in 3D Matrigel, we observed no statistically significant difference between Spry1het and Spry1KO basal cells in acinusforming efficiency ( Fig. S2 C and D) . Together, these results suggest that Spry1 loss in basal cells is unlikely to have a major effect on mammary stem cell biology and to be the cause of the branching phenotype observed in Spry1KO mice.
Another possibility is that Spry1-null epithelium undergoes branching more readily than normal during postpubertal development. To examine this possibility, we performed 3D in vitro culture studies in which mammary epithelium forms branches in response to growth factor treatment (30) . Mammary epithelium did not branch in the absence of growth factors but was able to form branched structures in the presence of FGF2 or FGF7 ( Fig.  S2E ). We found no significant differences between Spry1het organoids and Spry1KO organoids in their responses to FGF2 or FGF7 in terms of proportion of branched organoids ( Fig. 2C ) or number of branches per organoid ( Fig. S2F ). These data suggest that Spry1-null epithelium is not defective and responds to branching signals similarly to control epithelium.
To test whether loss of epithelial Spry1 affects mammary branching in vivo, we transplanted 10,000 mammary epithelial cells (MECs) from Spry1het and Spry1KO mice into "cleared" fat pads lacking the endogenous epithelial network of the #4 mammary gland in 3-wk-old nude mice ( Fig. S2G ). Five weeks after surgery, we harvested transplants and stained them with carmine red. We found that MECs derived from both Spry1het and Spry1KO mice formed epithelial networks, but no significant difference was detected in epithelial branching ( Fig. 2 D and E) .
These results show that the loss of Spry1 in the epithelium does not affect mammary gland branching and is unlikely to be the cause of accelerated branching in Spry1KO mice.
Loss of Spry1 in Stromal Cells Promotes Increased Epithelial Branching
in Vitro. To determine whether Spry1-null stroma promotes increased epithelial branching, we developed an in vitro assay in which wild-type organoids were cocultured with fibroblasts harvested from Spry1het and Spry1KO mice. Mammary organoids did not form branched structures when cultured in basal medium alone ( Fig. 2F ). However, when they were cocultured with fibroblasts, mammary organoids formed branches in 4-5 d ( Fig. 2F) , with more branches forming when more fibroblasts and organoids were present.
When cocultured with Spry1KO fibroblasts, the organoids branched more readily and formed more branches than with Spry1het fibroblasts ( Fig. 2 G and H) . This observation is consistent with the in vivo phenotype and suggests that Spry1-null stroma promotes epithelial branching more strongly than controls.
These results indicate that the ductal phenotype arising from the loss of Spry1 arises from defects within the stroma, rather than within the epithelium.
In Mammary Fibroblasts, Spry1 Is a Negative Regulator of EGFR-ERK Signaling in Response to AREG and TGFα. Sprouty genes regulate RTK signaling in various developmental contexts (37, 38) . Therefore, we used Western blotting to examine the phosphorylation and activation status of protein kinase B (AKT) and extracellular signal-regulated kinase (ERK), key components of the two main branches downstream of RTK signaling. We found that AKT activation (phospho-Ser473) was the same in Spry1het and Spry1KO fibroblasts ( Fig. 2 I and J) . In contrast, ERK phosphorylation at Thr202/Tyr204 was up-regulated in Spry1KO fibroblasts compared with Spry1het fibroblasts ( Fig. 2 I and K) . These data indicate that Spry1 loss leads to up-regulation of RTK signaling through the ERK arm of the pathway in mammary fibroblasts.
Next, we set out to determine whether Spry1 regulates signaling via EGFR, an RTK that mediates epithelium-to-stroma communication during mammary branching (24) . Interestingly, we found increased expression of candidate EGFR-responsive genes Egr1 and Fos (39, 40) in Spry1KO fibroblasts ( Fig. S3A ). Moreover, treatment of Spry1het and Spry1KO fibroblasts with EGFR ligands, including AREG ( Fig. 2 L and M) and TGFα ( Fig. 2 N and O) , led to an increase of the strength and duration of ERK activation in Spry1KO fibroblasts compared with Spry1het fibroblasts. By contrast, we observed no significant difference in AKT activation between Spry1het and Spry1KO fibroblasts in response to these two growth factors ( Fig. S3 B-E). Furthermore, expression of both Egr1 and Fos was up-regulated more strongly in Spry1KO fibroblasts than in Spry1het fibroblasts in response to AREG or TGFα treatment ( Fig. S3F ), suggesting that Spry1KO fibroblasts are sensitized to AREG/TGFα-EGFR-ERK signaling.
These results show that, when Spry1 is deleted in mammary fibroblasts, there is increased EGFR signaling and more epithelial branching. Thus, fibroblast Spry1 normally functions to negatively regulate AREG/TGFα-EGFR-ERK signaling.
Mammary Stromal Fibroblasts Lacking Spry1 Promote Epithelial
Expansion and Migration in a Paracrine Fashion. One mechanism by which Spry1-null fibroblasts might promote epithelial branching more strongly than normal is by increasing paracrine signaling to the epithelium. To examine this possibility, we developed an in vitro system in which aggregated fibroblasts, or "fibrospheres," were cultured with organoids in close proximity (∼100 μm). When cultured alone in basal medium without growth factors, organoids and fibrospheres gradually shrank over the course of 2 d (Fig. S4 ). However, when cultured together, we observed mutual interactions between organoids and fibrospheres. Specifically, in the presence of Spry1het fibrospheres, a majority of organoids underwent cyst formation, and some of these organoids also migrated toward the fibrospheres ( Fig. 3 A, E, and F, and Movie S1). Epithelial cyst formation and collective migration occurred at a higher frequency in the presence of Spry1KO fibrospheres ( Fig. 3 A, E, and F and Movie S2). Under both experimental conditions, we observed extensions composed of fibroblasts protruding from fibrospheres, often in the direction of organoid epithelium (Fig. 3A) .
The ability of fibrospheres to promote epithelial cyst formation and collective migration was increased by addition of AREG into the coculture (Fig. 3 B, E, and F) , whereas it was inhibited by the highly selective EGFR inhibitor BIBX1382 (41) (Fig. 3C) . These results suggest that the ability of fibrospheres to promote cyst formation and migration is positively regulated by EGFR signaling. Moreover, fibrosphere-induced epithelial response was rapid and was evident within 24 h ( Fig. 3A and Movies S1 and S2), unlike the assays in which organoids formed branches after several days. The results thus suggest that fibrosphere influence on the epithelium is based on paracrine growth factors.
FGF ligands play distinct roles in epithelial morphogenesis of the mammary gland and, when delivered locally on heparin beads rather than uniformly in the medium, can trigger cyst formation and/or collective migration similar to fibrospheres (42) . Thus, likely candidates by which fibrospheres influence the epithelium are FGF ligands, which are major epithelial branching signals produced in the mammary gland stroma. Indeed, the addition of FGFR signaling inhibitor SU5402 at 20 μM, the concentration at which it selectively inhibits FGFR but not insulin receptor or PDGFR (43) , effectively abrogated fibrosphere-induced epithelial morphogenesis ( Fig. 3 D-F ), suggesting that fibroblast-derived signals are, at least in part, ligands of the FGF family. Accordingly, we hypothesized that, if FGFs are indeed responsible for the Spry1 loss-of-function phenotype, then FGF production would be higher in Spry1KO fibroblasts than in Spry1het fibroblasts. To test this hypothesis, we examined mRNA expression of several Fgfs that are expressed in the mammary gland stroma (42) . As predicted, some of these Fgfs, including Fgf1, Fgf7, Fgf8, Fgf9, and Fgf10 were more highly expressed in Spry1KO fibroblasts than in Spry1het fibroblasts ( Fig. 3G) . Interestingly, Igf1, another growth factor that promotes mammary gland development (14) , was also up-regulated at the mRNA level in Spry1KO fibroblasts (Fig. 3G) .
These results reveal that stromal fibroblasts can promote epithelial branching by providing growth factors, particularly those of the FGF family. In the Spry1KO fibroblasts, paracrine production is higher than in Spry1het cells, leading to an increase in ductal branching.
Loss of Spry1 Increases Collagen Remodeling and Promotes Epithelial
Invasion. Another mechanism by which Spry1KO stromal fibroblasts might promote epithelial branching more strongly than normal is by modulating ECM remodeling, which is essential for epithelial behavior, including invasion and branching morphogenesis (1, 20) . To test this possibility, we used a collagen contraction assay, in which remodeling of collagen matrix leads to contraction, to compare the ECM remodeling abilities between Spry1het fibroblasts and Spry1KO fibroblasts (Fig. 4A ). We found that Spry1KO fibroblasts contracted collagen matrix more strongly than Spry1het fibroblasts ( Fig. 4 B and C) . Moreover, treatment with the EGFR inhibitor BIBX1382 attenuated collagen contraction abilities of Spry1het and Spry1KO fibroblasts ( Fig. 4 B and  C) , suggesting that EGFR signaling regulates collagen remodeling in mammary fibroblasts.
Using qPCR, we next examined expression of several ECMremodeling genes, including matrix metalloproteinases (Mmps) and lysyl oxidases (Lox, Lox3) in stromal fibroblasts. Compared with Spry1het fibroblasts, we found that expression of Mmp2, Mmp11, Mmp14, Lox, and Lox3 was up-regulated in Spry1KO fibroblasts (Fig. 4D) . These data suggest that Spry1-null fibroblasts promote epithelial branching in part by up-regulating expression of ECM-remodeling enzymes.
We also examined collagen deposition during mammary development by staining sections with Picrosirius red. The amount of organized collagen progressively increased with age ( Fig. 4 E and F), and there was a higher amount of organized collagen in Spry1KO glands than in Spry1het glands (Fig. 4F) . Thus, the ECM becomes altered in Spry1KO mice.
Next, we investigated whether increased collagen-remodeling activity of Spry1KO fibroblasts could promote epithelial cell invasion. To this end, we used an organotypic invasion assay in which fibroblast-mediated ECM remodeling activity, rather than paracrine signaling, is the primary factor affecting epithelial/cancer cell invasion (44) . Because primary MECs do not invade in this experimental setting, we used a stable breast cancer cells line MCF7-ras, which invades depending on fibroblast-mediated ECM remodeling. We measured matrix invasion by the MCF7-ras cells, which had been seeded on top of a dense collagen/Matrigel matrix embedded with either Spry1het or Spry1KO fibroblasts, 8 d after the coculture (Fig. 4G ). We found that MCF7-ras cells invaded significantly deeper into the matrix remodeled by Spry1KO fibroblasts than by Spry1het fibroblasts ( Fig. 4 H and I and Fig. S4B ), indicating that Spry1KO fibroblasts are more effective at promoting epithelial invasion.
These results indicate that Spry1KO fibroblasts contribute to epithelial branching more strongly than normal, by up-regulating ECM remodeling. This upregulation of matrix remodeling is in part due to an increased expression of ECM-remodeling enzymes.
Reduction of Stromal EGFR Signaling Leads to Decreased Epithelial
Branching in Vivo. A prediction that follows from our finding that up-regulation of EGFR signaling due to Spry1 loss in stromal fibroblasts causes accelerated epithelial branching, is that reduction of EGFR signaling, for example, by gain of Spry1 function in the mammary stroma, will lead to stunted epithelial branching. SPRY1 and SPRY2 are biochemically similar and play redundant roles in the same cellular context (33, 37, 45) . We therefore exploited a mouse line carrying a conditional Spry2 gainof-function allele (Spry2-GOF) (30, 46) . We first determined whether Cre-mediated recombination could activate Spry2-GOF and, if so, whether Spry2-GOF could reduce EGFR signaling in the mammary stroma. To this end, we exposed fibroblasts from control and Spry2-GOF mice to adenovirus (Ad)-Cre-GFP, resulting in a high proportion expressing GFP (Fig. 5A) . We then examined the responses of Ad-Cre-GFP-infected control and Spry2-GOF fibroblasts to AREG and TGFα treatment by Western blot analysis. As expected, AKT activation was unaffected by Spry2 gain of function ( Fig. S5 A-D) . By contrast, ERK activation in Spry2-GOF fibroblasts was reduced compared with control fibroblasts (Fig. 5 B-E) . Thus, ectopic expression of Spry2 dampens AREG/TGFα-ERK signaling, validating the use of the Spry2-GOF mouse line to reduce EGFR signaling in stromal fibroblasts.
We crossed Spry2-GOF mice with Fsp-Cre mice [which have Cre activity in mammary fibroblasts (47) ] to generate Fsp-Cre; Spry2-GOF female progeny, in which Spry2-GOF was activated in the mammary stroma ( Fig. S5E) and there was down-regulated EGFR signaling (Fig. S5F ). We found that, when the mammary glands of Fsp-Cre;Spry2-GOF mice were compared with those of controls at 5, 8, or 12 wk of age, ductal penetration and branch formation were reduced ( Fig. 5 F-I) .
These results confirm that reducing EGFR signaling in stromal fibroblasts leads to decreased epithelial branching in vivo.
Discussion
In this study, we have gained insights into the nature of epithelialstromal interactions in mammary gland development. We show that Spry1 modulates epithelial-stromal interactions by negatively regulating EGFR-dependent stromal paracrine signaling and ECM remodeling (Fig. 5J) . Loss of Spry1 leads to up-regulated EGFR signaling and enhanced stromal activities, including ECM remodeling and growth factor production, which in turn leads to increased epithelial branching. By contrast, down-regulation of EGFR signaling in fibroblasts leads to stunted epithelial branching. Taken together with our findings of the significance of FGFR signaling within the epithelium (15, 16, 42) , the results show that EGFR and FGFR signaling constitute a critical part of the molecular basis of stromal-epithelial interactions during postnatal development, and their modulation by Sprouty genes is essential for mammary gland formation and homeostasis.
Spry1 Is Haplosufficient for Normal Mammary Gland Development. In agreement with Spry1 haplosufficiency in development of kidney, urinary tract, and external genitalia (27, 33) , our study revealed that Spry1 is haplosufficient during mammary development because we did not observe any difference in mammary branching between Spry1wt and Spry1het glands. The relatively minor phenotype of Spry1KO mammary glands suggests that loss of Spry1 might be compensated by other stromal Sprouty genes. Indeed, we found that Spry4 shows a similar expression pattern as Spry1 in the developing mammary gland, suggesting that it may play a redundant function as Spry1. Future studies of other Sprouty genes in the mammary gland stroma, alone or in combination with Spry1, should address this question regarding whether they play a similar or distinct role during mammary gland development.
It remains unclear why Spry1 expression remains relatively stable throughout postpubertal development of the mammary gland but is greatly up-regulated at the 10-wk stage, when branching morphogenesis has all but finished in the adult female mice. One intriguing explanation for this observation is that, consistent with it being a negative regulator of mammary epithelial branching, Spry1 may be up-regulated by an increased production of certain growth factor(s) to function as a critical component to halt the epithelial movement when the mammary tree has already been built and "unwanted"/dysregulated epithelial invasiveness beyond this point could harm the integrity and homeostasis of the functional mammary gland as in the case of breast cancer development.
Stromal EGFR Signaling Promotes Epithelial Branching by Regulating ECM Remodeling. Although it is well established that EGFR expression in the mammary gland stroma is required for epithelial branching, the mechanism by which EGFR signaling functions in the stroma has remained largely unclear. Our data show that are consistent with a previous report on regulation of Mmp expression and collagen contraction by EGFR-ERK signaling in mouse embryonic fibroblasts (48) . Importantly, several Mmps, including Mmp2, Mmp3, and Mmp14, have been shown to regulate mammary epithelial branching in vivo (49, 50) . Consistent with increased Mmp and Lox gene expression, we found that organized collagen deposition was higher in Spry1KO mammary glands than in Spry1het glands during development. Although it remains unclear whether the increased deposition of organized collagen directly causes increased epithelial branching in Spry1KO mammary glands, emerging evidence now shows that stiffness of the ECM, including collagen, plays an important role in regulating epithelial behavior (reviewed in refs. 6, 20, and 51) . Indeed, MCF7-ras cells invaded significantly deeper in the ECM that had been remodeled by Spry1KO fibroblasts than by Spry1het fibroblasts. These results thus suggest that epithelial invasion, an important aspect of vertebrate epithelial branching, is increased in the absence of Spry1. Terminal end buds (TEBs) develop at the onset of puberty (3 wk after birth) at the distal tip of each primary duct, which invades the stroma in a proximal (pr)-to-distal (di) direction. Epithelial EGF ligands, including AREG and TGFα, activate EGFR signaling that is essential for FGF paracrine production and ECM remodeling. Levels of EGFR signaling are finetuned by stromal SPRY1 function so that an appropriate amount of FGFs and ECM-remodeling enzymes are produced during branching. By contrast, the interpretation of FGF activation by their receptors FGFR1/2 on the epithelium is modulated by SPRY2. As such, ductal elongation, collective migration, and other cell behavior essential for epithelial branching are orchestrated for the formation of the mammary gland.
It is interesting that organized collagen deposition progressively increased with time during normal development. These results are consistent with an increase in collagen bundles and ECM stiffness in the stromal microenvironment in mouse tumor models (6) . Taken together, the increased epithelial branching observed in Spry1KO mice is most likely a direct result of up-regulation of EGFR-ERK signaling in mutant stroma due to Spry1 loss.
EGFR and FGFR Signaling Pathways Underlie Stromal-Epithelial
Interactions During Postnatal Mammary Gland Development. In the presence of fibrospheres, mammary epithelium underwent rapid cyst formation and collective migration, suggesting that fibroblast influence is likely to be paracrine in nature. Interestingly, similar epithelial responses could be triggered by local delivery, as in the case of fibrospheres, of FGF ligands (42) . The data thus point to FGFs as candidate mediators of the epithelial responses. Indeed, the addition of the FGFR inhibitor SU5402 abolished cyst formation and epithelial migration, suggesting that stroma-derived paracrine factors can, at least in part, be ascribed to ligands of the FGF family. This notion was confirmed by gene expression analysis based on qPCR, which showed that several stromal Fgfs were more strongly expressed in Spry1KO fibroblasts than in Spry1het fibroblasts.
Thus, the increased epithelial branching in Spry1KO gland is caused by overproduction of FGF ligands and possibly other paracrine factors, including IGF1, due to EGFR signaling up-regulation in the mutant stroma. This conclusion is consistent with the observation that increased epithelial branching can also directly result from FGF signaling up-regulation in the absence of its inhibitor SPRY2 in the epithelium (30) . By contrast, EGFR signaling down-regulation due to gain of Sprouty function in the stromal fibroblasts led to retardation of epithelial branching. Indeed, epithelial branching is severely retarded or absent in the mammary stroma lacking Egfr function (24) or in the mammary epithelium lacking Fgfr (15, 16, 42) .
Taken together, a reciprocal cross-talk mechanism exists in the developing mammary gland to regulate epithelial morphogenesis (Fig. 5J ). On the one hand, epithelium-derived EGF family ligands, including AREG and TGFα, are essential for epithelial branching by targeting the mammary stroma. On the other hand, upon activation by AREG and TGFα, EGFR signaling promotes epithelial branching by a dual mechanism: indirectly by enhancing ECM remodeling and subsequently epithelial invasion, and directly by producing paracrine factors, including FGF ligands that target mammary epithelium via FGFR1 and FGFR2 signaling. Importantly, our data do not exclude the possibility that Spry1 may regulate other RTKs, including IGFR, FGFR, or PDGFR in fibroblasts. Future studies will address whether these RTKs function in the mammary gland stroma and, if so, whether they are regulated by Spry1.
Reciprocal cross talk between epithelium and mesenchyme is a central theme in developmental biology, and this type of interaction is responsible for the specification, differentiation, and morphogenesis of many vertebrate organs during embryonic development (7) . Our studies and others show that the mammary stroma, a derivative of embryonic mammary mesenchyme, engages in a similar cross talk with the epithelium during postnatal development, and perhaps in tissue homeostasis. A key aspect of future studies will be to understand how deregulation of stromal-epithelial cross talk may contribute to tumor onset and progression in the breast.
A Model of Sprouty Gene Function in Epithelial Branching of the Mammary Gland. Our working model is that SPRY1 suppresses overactive epithelial branching by inhibiting EGFR-dependent paracrine signaling and ECM remodeling in the mammary gland stroma (Fig. 5J ). In the absence of SPRY1, epithelial branching is increased because paracrine signaling and ECM remodeling in the stromal microenvironment is augmented. By contrast, SPRY2 suppresses precocious epithelial branching by inhibiting FGFR signaling in the epithelium (30) . In the absence of SPRY2, epithelial branching is increased because the epithelium is more sensitized to FGF stimulation, and undergoes epithelial expansion, collective migration, and other essential aspects of epithelial branching more readily than normal.
It is interesting that different members of the Sprouty gene family are deployed in different tissues to modulate the reciprocal signaling between epithelium and stroma, thereby ensuring that overactive epithelial branching is prevented. Whether SPRY1 functions as an extrinsic "brake," or SPRY2 acts as an intrinsic one in epithelial branching, they appear to perform the same function. The use of different Sprouty family members to fine-tune signaling between epithelium and mesenchyme reinforces the robustness of complex biological systems so that they can better withstand fluctuations of essential intrinsic or extrinsic factors during development and homeostasis.
Materials and Methods
Mouse Strains and Surgery. Immunologically deficient female nude (nu/nu) mice were from Charles River Laboratories. CD-1 mice were obtained from institutional mouse colony (University of Manchester). Mice carrying the Fsp-Cre allele (47) were purchased from The Jackson Laboratory. Mice carrying the Spry1 LacZ (31) allele and Spry2-GOF mice (46) were provided by M. Albert Basson, Department of Developmental and Stem Cell Biology, King's College of London, United Kingdom. Because Sprouty genes are haplosufficient for various vertebrate developmental processes (27, 32, 33) , we adopted a mating scheme wherein a Spry1 LacZ/LacZ male mouse was crossed with a Spry1 LacZ/+ female mouse so that Spry1het control and Spry1KO mutant female mice were generated at a 1:1 ratio and this was in compliance with the United Kingdom's 3Rs policy. Mice were housed and maintained according to the Animal (Scientific Procedures) Act, 1986 (UK), project licence PPL 40/9865, and approved by the University of Manchester Ethical Review Process Committee and by ShanghaiTech University's Institutional Animal Care and Use Committee (IACUC# 2015SHT0006), and were genotyped according to methods in the publications describing establishment of the mouse lines.
Isolation and Culture of Primary Mammary Organoids and Fibroblasts. Primary mammary organoids were isolated and cultured as previously described (30) . Briefly, mouse mammary glands were finely chopped, and mince was digested in collagenase buffer [with 0.2% collagenase (Sigma) and 0.2% trypsin (Life Technologies)]. Samples were centrifuged, washed several times, and treated with DNase I. Then they were subjected to five rounds of differential centrifugation (a short-pulse centrifugation at 450 × g), during which supernatant was collected and pellets were resuspended in DMEM/F12 (Invitrogen) for another round of differential centrifugation. The pellet containing mammary organoids was either plated in Matrigel (Corning) and overlaid with basal medium (DMEM/F12, 10 μg/mL insulin, 5.5 μg/mL transferrin, 6.7 ng/mL selenium, 100 U/ mL penicillin, and 100 μg/mL streptomycin), supplemented with 2.5 nM FGF2 or FGF7 if needed (for in vitro epithelial branching assay), or the organoids were further trypsinized to obtain a single-celled MEC solution (for FACS). Supernatant fractions were pooled and centrifuged, and pellets were resuspended in Fibroblast medium [DMEM (Invitrogen) with 10% (vol/vol) FBS (Sigma), 10 μg/ mL insulin, 5.5 μg/mL transferrin, 6.7 ng/mL selenium, 100 U/mL penicillin, and 100 μg/mL streptomycin] and seeded on a cell culture dish. After 30 min, when fibroblasts had already adhered to the dish whereas other cellular types remained in suspension, medium was aspirated and cell culture dish was washed twice with PBS and fresh Fibroblast medium was added. To prepare fibrospheres, fibroblasts were aggregated in low-adhesion plates overnight.
See SI Materials and Methods for additional details and more methods, including mammosphere and acinar assay, RNA isolation and qPCR (Table S1) , mammary gland staining, in vitro epithelial branching and migration assays, Western blotting, collagen contraction and organotypic invasion assays, and statistical analyses.
